Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 118,804 | 105,412 | 45,561 | 558 | 25,300 |
| Cost of Goods | 2,114 | 5,224 | 9,612 | 0 | 0 |
| Gross Profit | 116,690 | 100,188 | 35,949 | 558 | 25,300 |
| Operating Expenses | 334,080 | 260,607 | 310,127 | 205,618 | 102,123 |
| Operating Income | -217,276 | -160,195 | -273,566 | -205,060 | -76,823 |
| Interest Expense | 18,149 | 8,075 | 153 | 199 | 232 |
| Other Income | 875 | 6,298 | 0 | -15,613 | -46,548 |
| Pre-tax Income | -234,550 | -161,972 | -273,719 | -220,872 | -123,603 |
| Income Tax | -3,394 | 630 | 439 | 0 | 0 |
| Net Income Continuous | -231,156 | -162,602 | -274,158 | -220,872 | -123,603 |
| Net Income | $-231,156 | $-162,602 | $-274,158 | $-220,872 | $-123,603 |
| EPS Basic Total Ops | -1.23 | -0.87 | -1.49 | -1.34 | -0.93 |
| EPS Basic Continuous Ops | -1.23 | -0.87 | -1.49 | -1.34 | -0.93 |
| EPS Diluted Total Ops | -1.23 | -0.87 | -1.49 | -1.34 | -0.93 |
| EPS Diluted Continuous Ops | -1.23 | -0.87 | -1.49 | -1.34 | -0.93 |
| EPS Diluted Before Non-Recurring Items | -1.18 | -0.87 | -1.49 | -1.34 | -0.93 |
| EBITDA(a) | $-204,521 | $-151,381 | $-269,430 | $-196,753 | $-72,209 |